Cargando…

Is dynamometry able to infer the risk of muscle mass loss in patients with COPD?

INTRODUCTION: Sarcopenia is characterized by a progressive and generalized decrease of strength and muscle mass. Muscle mass loss is prevalent in patients with chronic obstructive pulmonary disease (COPD) as a result of both the disease and aging. Some methods have been proposed to assess body compo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos, Dionei, Bertolini, Giovana Navarro, Leite, Marceli Rocha, Carvalho Junior, Luiz Carlos Soares, da Silva Pestana, Paula Roberta, dos Santos, Vanessa Ribeiro, Fortaleza, Ana Claudia de Souza, Rodrigues, Fernanda Maria Machado, Ramos, Ercy Mara Cipulo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516177/
https://www.ncbi.nlm.nih.gov/pubmed/26229459
http://dx.doi.org/10.2147/COPD.S69829
_version_ 1782383023729147904
author Ramos, Dionei
Bertolini, Giovana Navarro
Leite, Marceli Rocha
Carvalho Junior, Luiz Carlos Soares
da Silva Pestana, Paula Roberta
dos Santos, Vanessa Ribeiro
Fortaleza, Ana Claudia de Souza
Rodrigues, Fernanda Maria Machado
Ramos, Ercy Mara Cipulo
author_facet Ramos, Dionei
Bertolini, Giovana Navarro
Leite, Marceli Rocha
Carvalho Junior, Luiz Carlos Soares
da Silva Pestana, Paula Roberta
dos Santos, Vanessa Ribeiro
Fortaleza, Ana Claudia de Souza
Rodrigues, Fernanda Maria Machado
Ramos, Ercy Mara Cipulo
author_sort Ramos, Dionei
collection PubMed
description INTRODUCTION: Sarcopenia is characterized by a progressive and generalized decrease of strength and muscle mass. Muscle mass loss is prevalent in patients with chronic obstructive pulmonary disease (COPD) as a result of both the disease and aging. Some methods have been proposed to assess body composition (and therefore identify muscle mass loss) in this population. Despite the high accuracy of some methods, they require sophisticated and costly equipment. AIM: The purpose of this study was to infer the occurrence of muscle mass loss measured by a sophisticated method (dual energy X-ray absorptiometry [DEXA]) using a more simple and affordable equipment (dynamometer). METHODS: Fifty-seven stable subjects with COPD were evaluated for anthropometric characteristics, lung function, functional exercise capacity, body composition, and peripheral muscle strength. A binary logistic regression model verified whether knee-extension strength (measured by dynamometry) could infer muscle mass loss (from DEXA). RESULTS: Patients with decreased knee-extension strength were 5.93 times more likely to have muscle mass loss, regardless of sex, disease stage, and functional exercise capacity (P=0.045). CONCLUSION: Knee-extension dynamometry was able to infer muscle mass loss in patients with COPD.
format Online
Article
Text
id pubmed-4516177
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-45161772015-07-30 Is dynamometry able to infer the risk of muscle mass loss in patients with COPD? Ramos, Dionei Bertolini, Giovana Navarro Leite, Marceli Rocha Carvalho Junior, Luiz Carlos Soares da Silva Pestana, Paula Roberta dos Santos, Vanessa Ribeiro Fortaleza, Ana Claudia de Souza Rodrigues, Fernanda Maria Machado Ramos, Ercy Mara Cipulo Int J Chron Obstruct Pulmon Dis Original Research INTRODUCTION: Sarcopenia is characterized by a progressive and generalized decrease of strength and muscle mass. Muscle mass loss is prevalent in patients with chronic obstructive pulmonary disease (COPD) as a result of both the disease and aging. Some methods have been proposed to assess body composition (and therefore identify muscle mass loss) in this population. Despite the high accuracy of some methods, they require sophisticated and costly equipment. AIM: The purpose of this study was to infer the occurrence of muscle mass loss measured by a sophisticated method (dual energy X-ray absorptiometry [DEXA]) using a more simple and affordable equipment (dynamometer). METHODS: Fifty-seven stable subjects with COPD were evaluated for anthropometric characteristics, lung function, functional exercise capacity, body composition, and peripheral muscle strength. A binary logistic regression model verified whether knee-extension strength (measured by dynamometry) could infer muscle mass loss (from DEXA). RESULTS: Patients with decreased knee-extension strength were 5.93 times more likely to have muscle mass loss, regardless of sex, disease stage, and functional exercise capacity (P=0.045). CONCLUSION: Knee-extension dynamometry was able to infer muscle mass loss in patients with COPD. Dove Medical Press 2015-07-21 /pmc/articles/PMC4516177/ /pubmed/26229459 http://dx.doi.org/10.2147/COPD.S69829 Text en © 2015 Ramos et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Ramos, Dionei
Bertolini, Giovana Navarro
Leite, Marceli Rocha
Carvalho Junior, Luiz Carlos Soares
da Silva Pestana, Paula Roberta
dos Santos, Vanessa Ribeiro
Fortaleza, Ana Claudia de Souza
Rodrigues, Fernanda Maria Machado
Ramos, Ercy Mara Cipulo
Is dynamometry able to infer the risk of muscle mass loss in patients with COPD?
title Is dynamometry able to infer the risk of muscle mass loss in patients with COPD?
title_full Is dynamometry able to infer the risk of muscle mass loss in patients with COPD?
title_fullStr Is dynamometry able to infer the risk of muscle mass loss in patients with COPD?
title_full_unstemmed Is dynamometry able to infer the risk of muscle mass loss in patients with COPD?
title_short Is dynamometry able to infer the risk of muscle mass loss in patients with COPD?
title_sort is dynamometry able to infer the risk of muscle mass loss in patients with copd?
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516177/
https://www.ncbi.nlm.nih.gov/pubmed/26229459
http://dx.doi.org/10.2147/COPD.S69829
work_keys_str_mv AT ramosdionei isdynamometryabletoinfertheriskofmusclemasslossinpatientswithcopd
AT bertolinigiovananavarro isdynamometryabletoinfertheriskofmusclemasslossinpatientswithcopd
AT leitemarcelirocha isdynamometryabletoinfertheriskofmusclemasslossinpatientswithcopd
AT carvalhojuniorluizcarlossoares isdynamometryabletoinfertheriskofmusclemasslossinpatientswithcopd
AT dasilvapestanapaularoberta isdynamometryabletoinfertheriskofmusclemasslossinpatientswithcopd
AT dossantosvanessaribeiro isdynamometryabletoinfertheriskofmusclemasslossinpatientswithcopd
AT fortalezaanaclaudiadesouza isdynamometryabletoinfertheriskofmusclemasslossinpatientswithcopd
AT rodriguesfernandamariamachado isdynamometryabletoinfertheriskofmusclemasslossinpatientswithcopd
AT ramosercymaracipulo isdynamometryabletoinfertheriskofmusclemasslossinpatientswithcopd